acrylamideWhat was measured
Measured, with no finding
445 endpoints
Show what was measuredHide what was measured
Correlation of energy-adjusted acrylamide intake with alcohol intake
decreases
The highest correlations between energy-adjusted acrylamide intake and dietary factors were between acrylamide intake and coffee (r=0.63), fried potatoes (r=0.50), fiber (r=0.25), rye bread (r=0.23), and alcohol intake (r=−0.22)
PMID 20859673 · one of two readings recorded this
Correlation of energy-adjusted acrylamide intake with coffee intake
increases
The highest correlations between energy-adjusted acrylamide intake and dietary factors were between acrylamide intake and coffee (r=0.63), fried potatoes (r=0.50), fiber (r=0.25), rye bread (r=0.23), and alcohol intake (r=−0.22)
PMID 20859673 · one of two readings recorded this
Correlation of energy-adjusted acrylamide intake with fiber intake
increases
The highest correlations between energy-adjusted acrylamide intake and dietary factors were between acrylamide intake and coffee (r=0.63), fried potatoes (r=0.50), fiber (r=0.25), rye bread (r=0.23), and alcohol intake (r=−0.22)
PMID 20859673 · one of two readings recorded this
Correlation of energy-adjusted acrylamide intake with fried potatoes intake
increases
The highest correlations between energy-adjusted acrylamide intake and dietary factors were between acrylamide intake and coffee (r=0.63), fried potatoes (r=0.50), fiber (r=0.25), rye bread (r=0.23), and alcohol intake (r=−0.22)
PMID 20859673 · one of two readings recorded this
Correlation of energy-adjusted acrylamide intake with rye bread intake
increases
The highest correlations between energy-adjusted acrylamide intake and dietary factors were between acrylamide intake and coffee (r=0.63), fried potatoes (r=0.50), fiber (r=0.25), rye bread (r=0.23), and alcohol intake (r=−0.22)
PMID 20859673 · one of two readings recorded this
Dietary acrylamide intake from coffee
coffee 15.2 μg/day (40.4 %)
PMID 20859673 · one of two readings recorded this
Dietary acrylamide intake from fried potatoes
fried potatoes 5.47 μg/day (14.6 %)
PMID 20859673 · one of two readings recorded this
Dietary acrylamide intake from rye bread
and rye bread 5.26 μg/day (14.0 %)
PMID 20859673 · one of two readings recorded this
incidence of prostate, urothelial, colorectal, stomach, pancreatic, renal cell cancer and lymphoma, proportional hazards RR highest vs lowest quintile
no effect, no association observed
Not recorded as a finding: the only sentence is a lumped statement about 'other cancers' that names no single cancer, so no per-node span can be anchored; urothelial, renal and lymphoma have no node
No association was observed between acrylaimide intake and other cancers (Table 2).
PMID 20859673 · one of two readings recorded this
Incident colorectal cancer cases during follow-up
n = 316
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident lymphoma cases during follow-up
n = 175
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident pancreatic cancer cases during follow-up
n = 192
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident prostate cancer cases during follow-up
n = 799
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident renal cell cancer cases during follow-up
n = 184
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident stomach cancer cases during follow-up
n = 224
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Incident urothelial cancer cases during follow-up
n = 365
During the 10.2 years of follow-up 1703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers,224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed
PMID 20859673 · one of two readings recorded this
Lung cancer risk, age- and supplementation-adjusted
increases, p = 0.02, n = 1703
relative risk (RR) 1.26 (95% confidence interval (CI) 1.09–1.47), p for trend=0.02
PMID 20859673 · one of two readings recorded this
Lung cancer risk, cases in first 2 years excluded
no effect
When analyses were repeated with exclusion of the cases that occurred during the first 2 years the results were unchanged
PMID 20859673 · one of two readings recorded this
Lung cancer risk, multivariate-adjusted
increases, p = 0.02, n = 1703
RR 1.27 (95% CI 1.08–1.49), p for trend=0.02, respectively in the highest vs. lowest quintile
PMID 20859673 · one of two readings recorded this
Lung cancer risk, multivariate model further adjusted for coffee
no effect, p = 0.55
adjustment for coffee RR 1.12 (95% CI 0.92–1.36), p for trend=0.55
PMID 20859673 · one of two readings recorded this
Lung cancer risk, multivariate model further adjusted for fried potatoes
increases, p = 0.05
for fried potatoes RR 1.26 (95% CI 1.05–1.51), p for trend =0.05
PMID 20859673 · one of two readings recorded this
Lung cancer risk, multivariate model further adjusted for rye bread
increases, p = 0.02
for rye bread RR 1.25 (95% CI 1.07–1.47), p for trend=0.02
PMID 20859673 · one of two readings recorded this
Lung cancer risk
unclear, p = 0.03
RR of highest quintile vs. lowest 1.17 (95% CI 0.99–1.37), p for trend 0.03
PMID 20859673 · one of two readings recorded this
Lung cancer risk
no effect
Consumption of fried potatoes or rye bread were not associated with the risk of lung cancer
PMID 20859673 · one of two readings recorded this
other cancers pooled (prostate, urothelial, colorectal, stomach, pancreatic, renal cell, lymphoma), incidence by quintile of acrylamide intake
no effect, No association observed
Not recorded as a finding: The results sentence reports no association for 'other cancers' collectively with no per-site estimate; no per-site quoted sentence to anchor
No association was observed between acrylaimide intake and other cancers (Table 2).
PMID 20859673 · one of two readings recorded this
Other cancers (prostate, urothelial, colorectal, stomach, pancreatic, renal cell, lymphoma)
no effect
No association was observed between acrylaimide intake and other cancers
PMID 20859673 · one of two readings recorded this
Validation correlation, first questionnaire vs food records, dietary acrylamide
n = 190
The Spearman correlations between the first and second questionnaires and the food records were 0.73 and 0.43, respectively for dietary acrylamide
PMID 20859673 · one of two readings recorded this
Validation correlation, second questionnaire vs food records, dietary acrylamide
The Spearman correlations between the first and second questionnaires and the food records were 0.73 and 0.43, respectively for dietary acrylamide
PMID 20859673 · one of two readings recorded this
AAVal and GAVal change from 1. BS to 2. BS
decreases, p = 0.05
Signals for AAVal as well as GAVal (p < 0.05) of group A decreased from initial blood sampling (1. BS, begin of study) to the subsequent sampling time point (2. BS, day 7)
PMID 28534225 · one of two readings recorded this
AAVal and GAVal decline over 13-day washout
decreases, p = 0.05
the AAVal and GAVal levels declined at following blood sampling time points (p < 0.05)
PMID 28534225 · one of two readings recorded this
AAVal and GAVal response to high AA intake at 3. BS
increases, p = 0.05
Both values responded to high AA intake on day 10 within 3 days (3. BS, day 13; p < 0.05)
PMID 28534225 · one of two readings recorded this
Caloric intake on high AA day 10
The caloric intake on day 10 (high AA, group A) was 2897 kcal (+20%)
PMID 28534225 · one of two readings recorded this
Cumulative urinary 13C3D3-AAMA after 13C3D3-AA
13C3D3-AAMA (nmol) | 303 ± 39 | 377 ± 52 | 403 ± 58 | 412 ± 60 | 414 ± 62
PMID 28534225 · one of two readings recorded this
Cumulative urinary 13C3D3-AAMA after 13C3D3-AA
13C3D3-AAMA (nmol) | 303 ± 39 | 377 ± 52 | 403 ± 58 | 412 ± 60 | 414 ± 62
PMID 28534225 · one of two readings recorded this
Cumulative urinary 13C3D3-AAMA after 13C3D3-AA
13C3D3-AAMA (nmol) | 303 ± 39 | 377 ± 52 | 403 ± 58 | 412 ± 60 | 414 ± 62
PMID 28534225 · one of two readings recorded this
Cumulative urinary 13C3D3-AAMA after 13C3D3-AA
13C3D3-AAMA (nmol) | 303 ± 39 | 377 ± 52 | 403 ± 58 | 412 ± 60 | 414 ± 62
PMID 28534225 · one of two readings recorded this
Cumulative urinary 13C3D3-AAMA after 13C3D3-AA
13C3D3-AAMA (nmol) | 303 ± 39 | 377 ± 52 | 403 ± 58 | 412 ± 60 | 414 ± 62
PMID 28534225 · one of two readings recorded this
Cumulative urinary AAMA after high AA intake
AAMA (nmol) | 91 ± 54 | 3654 ± 824 | 5950 ± 780 | 6811 ± 865 | 7089 ± 875
PMID 28534225 · one of two readings recorded this
Cumulative urinary AAMA after high AA intake
AAMA (nmol) | 91 ± 54 | 3654 ± 824 | 5950 ± 780 | 6811 ± 865 | 7089 ± 875
PMID 28534225 · one of two readings recorded this
Cumulative urinary AAMA after high AA intake
AAMA (nmol) | 91 ± 54 | 3654 ± 824 | 5950 ± 780 | 6811 ± 865 | 7089 ± 875
PMID 28534225 · one of two readings recorded this
Cumulative urinary AAMA after high AA intake
AAMA (nmol) | 91 ± 54 | 3654 ± 824 | 5950 ± 780 | 6811 ± 865 | 7089 ± 875
PMID 28534225 · one of two readings recorded this
Cumulative urinary AAMA, washout day 9 (24 h)
AAMA (nmol) | 91 ± 54 | 3654 ± 824 | 5950 ± 780 | 6811 ± 865 | 7089 ± 875
PMID 28534225 · one of two readings recorded this
Cumulative urinary GAMA after high AA intake
GAMA (nmol) | 25 ± 12 | 270 ± 58 | 628 ± 115 | 774 ± 133 | 854 ± 149
PMID 28534225 · one of two readings recorded this
Cumulative urinary GAMA after high AA intake
GAMA (nmol) | 25 ± 12 | 270 ± 58 | 628 ± 115 | 774 ± 133 | 854 ± 149
PMID 28534225 · one of two readings recorded this
Cumulative urinary GAMA after high AA intake
GAMA (nmol) | 25 ± 12 | 270 ± 58 | 628 ± 115 | 774 ± 133 | 854 ± 149
PMID 28534225 · one of two readings recorded this
Cumulative urinary GAMA after high AA intake
GAMA (nmol) | 25 ± 12 | 270 ± 58 | 628 ± 115 | 774 ± 133 | 854 ± 149
PMID 28534225 · one of two readings recorded this
Cumulative urinary GAMA, washout day 9 (24 h)
GAMA (nmol) | 25 ± 12 | 270 ± 58 | 628 ± 115 | 774 ± 133 | 854 ± 149
PMID 28534225 · one of two readings recorded this
Estimated daily caloric intake during washout
The estimated daily caloric intake during washout was 2408 ± 83 kcal
PMID 28534225 · one of two readings recorded this
Fraction of 13C3D3-AA excreted as 13C3D3-AAMA
After 24 h 30% of 13C3D3-AA intake was excreted as 13C3D3-AAMA
PMID 28534225 · one of two readings recorded this
Fraction of 13C3D3-AA excreted as 13C3D3-AAMA
after 72 h 40%
PMID 28534225 · one of two readings recorded this
Fraction of 13C3D3-AA excreted as 13C3D3-AAMA
after 96 h in total 41% of the ingested 13C3D3-AA were excreted as 13C3D3-AAMA
PMID 28534225 · one of two readings recorded this
Fraction of ingested AA excreted as AAMA
After 24 h about 23% (15–29%) of ingested AA were excreted
PMID 28534225 · one of two readings recorded this
Fraction of ingested AA excreted as AAMA
after 96 h about 44% (38–51%)
PMID 28534225 · one of two readings recorded this
Fraction of ingested AA excreted as GAMA
Corresponding values for GAMA were about 2% (24 h) and about 5% (96 h)
PMID 28534225 · one of two readings recorded this
Fraction of ingested AA excreted as GAMA
Corresponding values for GAMA were about 2% (24 h) and about 5% (96 h)
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct AAVal, 1. BS
1. BS | 24.5 ± 19.7 | 46.4 ± 44.1 | 17.2 ± 16.0 | 27.5 ± 25.8
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct AAVal, 2. BS (day 7)
2. BS | 22.3 ± 17.6 | 38.4 ± 34.9 | 15.9 ± 14.5 | 23.3 ± 21.5
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct AAVal, 3. BS (day 13)
3. BS | 26.0 ± 16.1 | 34.0 ± 32.6 | 18.7 ± 13.5 | 20.9 ± 20.7
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct GAVal, 1. BS
1. BS | 24.5 ± 19.7 | 46.4 ± 44.1 | 17.2 ± 16.0 | 27.5 ± 25.8
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct GAVal, 2. BS (day 7)
2. BS | 22.3 ± 17.6 | 38.4 ± 34.9 | 15.9 ± 14.5 | 23.3 ± 21.5
PMID 28534225 · one of two readings recorded this
Hemoglobin adduct GAVal, 3. BS (day 13)
3. BS | 26.0 ± 16.1 | 34.0 ± 32.6 | 18.7 ± 13.5 | 20.9 ± 20.7
PMID 28534225 · one of two readings recorded this
N-terminal valine hemoglobin adducts AAVal and GAVal, UHPLC-ESI-MS/MS
increases, adduct levels responded to high AA intake within 3 days, n = 6
Not recorded as a finding: No node in the outcome list for hemoglobin adducts of acrylamide
Both values responded to high AA intake on day 10 within 3 days (3. BS, day 13; p < 0.05).
PMID 28534225 · one of two readings recorded this
urinary AAMA and GAMA mercapturic acid excretion after dietary acrylamide, creatinine-normalised, UHPLC-ESI-MS/MS
increases, AAMA excretion steeply increased after high-AA meal on day 10, n = 6
Not recorded as a finding: No node in the outcome list for urinary acrylamide mercapturic acid excretion
As seen from Fig. 4, after high AA intake at day 10 (14.1–15.9 µg/kg bw/d), a steep increase of AAMA and GAMA excretion was observed.
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion after coffee, day 6
increases
led to slightly enhanced urinary mean AAMA excretion (0.15 ± 0.06 µmol/d), as compared to 0.12 ± 0.05 µmol/d on the foregoing day 5
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion, day 1
excreting urinary AAMA amounts of 0.52 ± 0.39 µmol (0.29 ± 0.23 µmol/g ucr) on day 1
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion, day 5
decreases
continuously decreasing to 0.19 ± 0.14 µmol (0.08 ± 0.06 µmol/g ucr) on day 5
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion, day 9
decreases
Until day 9 the mean values of group A were decreasing to 0.09 ± 0.05 µmol/d (range 0.04–0.19 µmol/d)
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion, end of 13-day washout
decreases
the respective day 5 value (washout) of group B was 0.19 ± 0.14 µmol/d, decreasing towards the end of the study to 0.14 ± 0.10 µmol/d
PMID 28534225 · one of two readings recorded this
Urinary AAMA excretion, washout days 1 to 5
decreases
During the first washout phase (days 1–5) the AAMA excretion of group A decreased from 0.28 ± 0.14 µmol/d (0.16 ± 0.09 µmol/g ucr) to 0.12 ± 0.05 µmol/d (0.06 ± 0.04 µmol/g ucr)
PMID 28534225 · one of two readings recorded this
Urinary GAMA excretion, day 1 to day 5
decreases
The GAMA excretion (shown in Fig. 4 in relation to creatinine excretion) decreased in group A from 0.06 ± 0.01 µmol (0.03 ± 0.02 µmol/g ucr) on day 1 to 0.03 ± 0.01 µmol (0.02 ± 0.01 µmol/g ucr) on day 5
PMID 28534225 · one of two readings recorded this
Urinary GAMA excretion, day 1 to day 5
decreases
Values for GAMA in group B were 0.08 ± 0.06 µmol (0.04 ± 0.03 µmol/g ucr) on day 1 and 0.05 ± 0.03 µmol (0.02 ± 0.01 µmol/g ucr) on day 5
PMID 28534225 · one of two readings recorded this
urinary mercapturic acid (AAMA, GAMA) excretion after high dietary acrylamide intake, UHPLC-ESI-MS/MS
increases, steep increase of AAMA and GAMA excretion after 14.1-15.9 ug/kg bw
Not recorded as a finding: no outcome node for urinary acrylamide mercapturic acid excretion; also uncontrolled within-group change
As seen from Fig. 4, after high AA intake at day 10 (14.1–15.9 µg/kg bw/d), a steep increase of AAMA and GAMA excretion was observed.
PMID 28534225 · one of two readings recorded this
childhood overweight/obesity risk at age 3, 5 and 8, pooled OR
increases, OR 1.14 at age 3; 1.13 at age 5; 1.09 at age 8
Not recorded as a finding: no outcome node for childhood overweight/obesity incidence
In addition, pooled ORs suggested that children had a high risk of developing overweight/obesity in the future in maternal high AA exposure group (OR 1·14, 95 % CI 1·08, 1·21, P < 0·001 at age 3; OR 1·13, 95 % CI 1·07, 1·19, P < 0·001 at age 5; OR 1·09, 95 % CI 1·02, 1·16, P = 0·020 at age 8).
PMID 32349855 · one of two readings recorded this
Offspring birth weight
decreases, p = 0.005
Offspring's birth weight was significantly lower in high AA exposure group than in low AA exposure group (SMD -0·05, 95 % CI -0·09, -0·02, P = 0·005)
PMID 32349855 · one of two readings recorded this
Offspring overweight/obesity
increases, p = 0.001
OR 1·14, 95 % CI 1·08, 1·21, P < 0·001 at age 3
PMID 32349855 · one of two readings recorded this
Offspring overweight/obesity
increases, p = 0.001
OR 1·13, 95 % CI 1·07, 1·19, P < 0·001 at age 5
PMID 32349855 · one of two readings recorded this
Offspring overweight/obesity
increases, p = 0.02
OR 1·09, 95 % CI 1·02, 1·16, P = 0·020 at age 8
PMID 32349855 · one of two readings recorded this
small for gestational age (binary), pooled OR
increases, OR 1.14, 95% CI 1.06, 1.23
Not recorded as a finding: no outcome node for small-for-gestational-age incidence
There was also an association between maternal AA exposure and small for gestational age (OR 1·14, 95 % CI 1·06, 1·23, P < 0·001).
PMID 32349855 · one of two readings recorded this
small for gestational age, pooled OR; and overweight/obesity at ages 3, 5 and 8, pooled ORs
increases, SGA OR 1·14, 95 % CI 1·06, 1·23
Not recorded as a finding: No node in the outcome list for small-for-gestational-age or childhood overweight/obesity
There was also an association between maternal AA exposure and small for gestational age (OR 1·14, 95 % CI 1·06, 1·23, P < 0·001).
PMID 32349855 · one of two readings recorded this
Small for gestational age
increases, p = 0.001
There was also an association between maternal AA exposure and small for gestational age (OR 1·14, 95 % CI 1·06, 1·23, P < 0·001)
PMID 32349855 · one of two readings recorded this
contribution to total acrylamide intake
biscuits and cookies (men, 8.0%; women, 12.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
biscuits and cookies (men, 8.0%; women, 12.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
coffee (men, 32.0%; women, 23.6%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
coffee (men, 32.0%; women, 23.6%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
green tea (men, 20.2%; women, 22.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
green tea (men, 20.2%; women, 22.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
potatoes and starches (men, 10.4%; women, 12.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
potatoes and starches (men, 10.4%; women, 12.8%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
vegetables (men, 9.9%; women, 11.5%)
PMID 32806637 · one of two readings recorded this
contribution to total acrylamide intake
vegetables (men, 9.9%; women, 11.5%)
PMID 32806637 · one of two readings recorded this
incident lung cancer (ICD-O-3 C34) by cancer registry and hospital notification, Cox hazard ratio for quartiles and per 10 ug/day increment of energy-adjusted dietary acrylamide intake (FFQ), analysed separately in men and in women
no effect, p = 0.12
Not recorded as a finding: every result is a subgroup, with no whole-population estimate
No association was observed between daily acrylamide intake and lung cancer overall (p for trend = 0.12).
PMID 32806637 · one of two readings recorded this
incident lung cancer (ICD-O-3 C34, registry-ascertained) by quartile of energy-adjusted dietary acrylamide intake, multivariable Cox HR, analysed separately in men and in women
no effect, p = 0.12
Not recorded as a finding: every result is a subgroup, with no whole-population estimate
No association was observed between daily acrylamide intake and lung cancer overall (p for trend = 0.12).
PMID 32806637 · one of two readings recorded this
lung adenocarcinoma incident cases
there were 379 adenocarcinomas
PMID 32806637 · one of two readings recorded this
lung adenocarcinoma incident cases
there were 358 adenocarcinomas
PMID 32806637 · one of two readings recorded this
lung cancer incident cases
At the end of the follow-up period, 1187 lung cancer cases were newly identified in men
PMID 32806637 · one of two readings recorded this
lung cancer incident cases
A total of 485 cases were newly identified in women
PMID 32806637 · one of two readings recorded this
lung cancer risk, p for trend across quartiles
no effect, p = 0.12
No association was observed between daily acrylamide intake and lung cancer overall (p for trend = 0.12)
PMID 32806637 · one of two readings recorded this
lung cancer risk, p for trend across quartiles
no effect, p = 0.86
Acrylamide intake was not associated with lung cancer risk by increasing acrylamide intake both in the overall analysis (p for trend = 0.86) and sensitivity analysis (p for trend = 0.86)
PMID 32806637 · one of two readings recorded this
lung cancer risk, p for trend across quartiles
no effect, p = 0.86
Acrylamide intake was not associated with lung cancer risk by increasing acrylamide intake both in the overall analysis (p for trend = 0.86) and sensitivity analysis (p for trend = 0.86)
PMID 32806637 · one of two readings recorded this
lung cancer risk per 10-µg/day increment
no effect
The HR of lung cancer for 10-µg/day increment of acrylamide intake was 1.01 (95% CI, 0.99–1.02)
PMID 32806637 · one of two readings recorded this
lung cancer risk per continuous acrylamide intake
no effect
When acrylamide intake was considered a continuous variable, the HR was 0.98 (95% CI, 0.95–1.01)
PMID 32806637 · one of two readings recorded this
lung cancer risk per continuous acrylamide intake
no effect
no evidence of a decreased risk of lung cancer (HR, 0.98; 95% CI, 0.93–1.02) was observed when acrylamide intake was treated as a continuous variable
PMID 32806637 · one of two readings recorded this
lung squamous cell carcinoma incident cases
323 squamous cell carcinomas
PMID 32806637 · one of two readings recorded this
mean daily acrylamide intake
The mean (standard deviation) daily acrylamide intakes were 6.8 (3.9) µg/day in men and 7.0 (3.7) µg/day in women
PMID 32806637 · one of two readings recorded this
mean daily acrylamide intake
The mean (standard deviation) daily acrylamide intakes were 6.8 (3.9) µg/day in men and 7.0 (3.7) µg/day in women
PMID 32806637 · one of two readings recorded this
other and unclassified lung cancer incident cases
345 others and unclassified cases
PMID 32806637 · one of two readings recorded this
other and unclassified lung cancer incident cases
127 others and unclassified cases
PMID 32806637 · one of two readings recorded this
small-cell lung carcinoma incident cases
140 small-cell lung carcinomas
PMID 32806637 · one of two readings recorded this
contribution to dietary acrylamide intake
coffee (27.4%), green tea (21.6%), potato (11.0%), vegetables (10.8%), and biscuits (10.6%)
PMID 32825036 · one of two readings recorded this
contribution to dietary acrylamide intake
coffee (27.4%), green tea (21.6%), potato (11.0%), vegetables (10.8%), and biscuits (10.6%)
PMID 32825036 · one of two readings recorded this
contribution to dietary acrylamide intake
coffee (27.4%), green tea (21.6%), potato (11.0%), vegetables (10.8%), and biscuits (10.6%)
PMID 32825036 · one of two readings recorded this
contribution to dietary acrylamide intake
coffee (27.4%), green tea (21.6%), potato (11.0%), vegetables (10.8%), and biscuits (10.6%)
PMID 32825036 · one of two readings recorded this
contribution to dietary acrylamide intake
coffee (27.4%), green tea (21.6%), potato (11.0%), vegetables (10.8%), and biscuits (10.6%)
PMID 32825036 · one of two readings recorded this
incident liver cancer, multivariable Cox hazard ratio for highest vs lowest tertile of energy-adjusted dietary acrylamide intake (FFQ), model 1 and model 2 additionally adjusted for coffee
no effect
Not recorded as a finding: this platform holds no node for the endpoint
However, the statistically significant decrease disappeared after additional adjustment for coffee consumption (HR = 1.08; 95% CI = 0.87–1.34).
PMID 32825036 · one of two readings recorded this
incident liver cancer (registry-ascertained) by tertile of energy-adjusted dietary acrylamide intake, multivariable Cox HR, model 1 and model 2 (additionally adjusted for coffee)
decreases, p = 0.01
Not recorded as a finding: this platform holds no node for the endpoint
Subjects with a high acrylamide intake (T3) had a 21% lower liver cancer risk than those who had a low acrylamide intake (T1) (HR = 0.79; 95% CI = 0.65–0.95; P trend = 0.01) in model 1.
PMID 32825036 · one of two readings recorded this
liver cancer incident cases
744 cases of liver cancer were ascertained among the 85,305 eligible participants
PMID 32825036 · one of two readings recorded this
liver cancer risk, model 1, p for trend across tertiles
decreases, p = 0.01
(HR = 0.79; 95% CI = 0.65–0.95; P trend = 0.01) in model 1
PMID 32825036 · one of two readings recorded this
liver cancer risk, model 1
decreases
(HR = 0.79; 95% CI = 0.65–0.95; P trend = 0.01) in model 1
PMID 32825036 · one of two readings recorded this
liver cancer risk, model 1
decreases, p = 0.01
an increased acrylamide intake reduced the risk of liver cancer among coffee drinkers in the multivariable model 1 (HR = 0.74; 95% CI = 0.58–0.94; P trend = 0.01)
PMID 32825036 · one of two readings recorded this
liver cancer risk, model 2 (additionally adjusted for coffee consumption)
no effect
the statistically significant decrease disappeared after additional adjustment for coffee consumption (HR = 1.08; 95% CI = 0.87–1.34)
PMID 32825036 · one of two readings recorded this
liver cancer risk, model 2 (additionally adjusted for coffee consumption)
no effect
the inverse association disappeared after additional adjustment in the multivariable model 2 (HR = 1.05; 95% CI = 0.80–1.38)
PMID 32825036 · one of two readings recorded this
mean energy-adjusted acrylamide intake
the mean intake (±SD) of acrylamide by our study population was 6.9 ± 3.8 µg per day
PMID 32825036 · one of two readings recorded this
contribution to dietary acrylamide intake by quartile: biscuits/cookies
increases
biscuits or/and cookies: Q1: 6%, Q4: 13%
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake by quartile: coffee
increases
coffee: Q1: 14%, Q4: 36%
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake by quartile: vegetables
decreases
vegetables: Q1: 17%, Q4: 7%
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
vegetables (total 11%; 3% for sweet pepper, 3% for onion, 3% for bean sprouts, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
beverages (total 53%; 28% for coffee, 21% for green tea, 2% for beer, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
beverages (total 53%; 28% for coffee, 21% for green tea, 2% for beer, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
confections (total 16%; 11% for biscuits/cookies, 3% for chocolate, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
confections (total 16%; 11% for biscuits/cookies, 3% for chocolate, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
beverages (total 53%; 28% for coffee, 21% for green tea, 2% for beer, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
confections (total 16%; 11% for biscuits/cookies, 3% for chocolate, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
beverages (total 53%; 28% for coffee, 21% for green tea, 2% for beer, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
vegetables (total 11%; 3% for sweet pepper, 3% for onion, 3% for bean sprouts, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
vegetables (total 11%; 3% for sweet pepper, 3% for onion, 3% for bean sprouts, and 2% for others)
PMID 33266487 · one of two readings recorded this
contribution to dietary acrylamide intake
vegetables (total 11%; 3% for sweet pepper, 3% for onion, 3% for bean sprouts, and 2% for others)
PMID 33266487 · one of two readings recorded this
mean acrylamide intake per body weight
corresponding to 0.13 ± 0.16 μg/kg body weight/day
PMID 33266487 · one of two readings recorded this
mean acrylamide intake
The overall median acrylamide intake was 6.12 μg/d (IQR, 4.30–8.72), and the mean (SD) was 6.92 ± 3.81 μg/d
PMID 33266487 · one of two readings recorded this
median acrylamide intake
The overall median acrylamide intake was 6.12 μg/d (IQR, 4.30–8.72), and the mean (SD) was 6.92 ± 3.81 μg/d
PMID 33266487 · one of two readings recorded this
pancreatic cancer incident cases
During a mean follow-up of 15.2 years, 576 pancreatic cancer cases were identified
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.07
the HR of the highest quartile vs. the lowest was 0.83 (95% CI: 0.65–1.05) (p for trend = 0.07)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.2
consumption of <150 g/week of alcohol (p for trend = 0.20)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.11
BMI <25 kg/m2 (p for trend = 0.11)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.11
consumption of <1 cup/week of coffee (p for trend = 0.11)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.25
current or past smoking status (p for trend = 0.25)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.23
consumption of <1 cup/week of green tea (p for trend = 0.23)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk, p for trend across quartiles
no effect, p = 0.23
never smoking status (p for trend = 0.23)
PMID 33266487 · one of two readings recorded this
pancreatic cancer risk
no effect
the HR of the highest quartile vs. the lowest was 0.83 (95% CI: 0.65–1.05) (p for trend = 0.07)
PMID 33266487 · one of two readings recorded this
contribution to total acrylamide intake
coffee (27.4%), green tea (21.6%), potatoes and starches (11.0%), vegetables (10.8%), and biscuits and cookies (10.6%) mainly contributed to the total acrylamide intake
PMID 33670108 · one of two readings recorded this
contribution to total acrylamide intake
coffee (27.4%), green tea (21.6%), potatoes and starches (11.0%), vegetables (10.8%), and biscuits and cookies (10.6%) mainly contributed to the total acrylamide intake
PMID 33670108 · one of two readings recorded this
contribution to total acrylamide intake
coffee (27.4%), green tea (21.6%), potatoes and starches (11.0%), vegetables (10.8%), and biscuits and cookies (10.6%) mainly contributed to the total acrylamide intake
PMID 33670108 · one of two readings recorded this
contribution to total acrylamide intake
coffee (27.4%), green tea (21.6%), potatoes and starches (11.0%), vegetables (10.8%), and biscuits and cookies (10.6%) mainly contributed to the total acrylamide intake
PMID 33670108 · one of two readings recorded this
contribution to total acrylamide intake
coffee (27.4%), green tea (21.6%), potatoes and starches (11.0%), vegetables (10.8%), and biscuits and cookies (10.6%) mainly contributed to the total acrylamide intake
PMID 33670108 · one of two readings recorded this
incident malignant lymphoma, multiple myeloma and leukemia (ICD-O-3 morphology codes, registry and hospital ascertainment), multivariable Cox hazard ratio for dietary acrylamide intake tertiles
no effect
Not recorded as a finding: this platform holds no node for the endpoint
The results did not support that the daily acrylamide intake was associated with ML overall (HR for T2, 1.07; 95% CI: 0.82–1.40; HR for T3, 0.87; 95% CI 0.64–1.18).
PMID 33670108 · one of two readings recorded this
incident malignant lymphoma, multiple myeloma and leukemia (registry-confirmed, ICD-O-3 morphology codes) by tertile of energy-adjusted dietary acrylamide intake, multivariable Cox HR
no effect
Not recorded as a finding: this platform holds no node for the endpoint
The results did not support that the daily acrylamide intake was associated with ML overall (HR for T2, 1.07; 95% CI: 0.82–1.40; HR for T3, 0.87; 95% CI 0.64–1.18).
PMID 33670108 · one of two readings recorded this
leukemia incident cases
326, 126, and 224 new cases of ML, MM, and leukemia had been identified, respectively
PMID 33670108 · one of two readings recorded this
leukemia risk, interaction with smoking status
p = 0.13
representing p-value for interaction was 0.13
PMID 33670108 · one of two readings recorded this
leukemia risk, p for trend across tertiles
no effect, p = 0.94
(HR for T2, 1.01; 95% CI: 0.73–1.40; HR for T3, 1.01; 95% CI 0.71–1.45; p for trend = 0.94)
PMID 33670108 · one of two readings recorded this
leukemia risk, p for trend across tertiles
no effect, p = 0.89
(HR for T2, 1.04; 95% CI: 0.73–1.49; HR for T3, 1.03; 95% CI 0.70–1.52; p for trend = 0.89)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
(HR for T2, 1.01; 95% CI: 0.73–1.40; HR for T3, 1.01; 95% CI 0.71–1.45; p for trend = 0.94)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
(HR for T2, 1.01; 95% CI: 0.73–1.40; HR for T3, 1.01; 95% CI 0.71–1.45; p for trend = 0.94)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
the risks of leukemia for T2 (HR, 1.42; 95% CI, 0.78–2.59) and T3 (HR, 1.33; 95% CI, 0.69–2.59)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
For never smokers, the risks for T2 (HR, 0.82; 95%CI, 0.53–1.27) and T3 (HR, 0.86; 95%CI, 0.53–1.37)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
(HR for T2, 1.04; 95% CI: 0.73–1.49; HR for T3, 1.03; 95% CI 0.70–1.52; p for trend = 0.89)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
the risks of leukemia for T2 (HR, 1.42; 95% CI, 0.78–2.59) and T3 (HR, 1.33; 95% CI, 0.69–2.59)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
For never smokers, the risks for T2 (HR, 0.82; 95%CI, 0.53–1.27) and T3 (HR, 0.86; 95%CI, 0.53–1.37)
PMID 33670108 · one of two readings recorded this
leukemia risk
no effect
(HR for T2, 1.04; 95% CI: 0.73–1.49; HR for T3, 1.03; 95% CI 0.70–1.52; p for trend = 0.89)
PMID 33670108 · one of two readings recorded this
malignant lymphoma incident cases
326, 126, and 224 new cases of ML, MM, and leukemia had been identified, respectively
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk, interaction with smoking status
no effect, p = 0.38
The HRs for acrylamide intake did not differ by smoking status (p for interaction = 0.38)
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk, p for trend
no effect, p = 0.48
The risk of ever smokers also did not increase with increasing acrylamide intake (p for trend = 0.48)
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk
no effect
The HR for 10 µg per day increment of acrylamide intake was 0.98 (95% CI, 0.94–1.01)
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk
no effect
(HR for T2, 1.07; 95% CI: 0.82–1.40; HR for T3, 0.87; 95% CI 0.64–1.18)
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk
no effect
(HR for T2, 1.07; 95% CI: 0.82–1.40; HR for T3, 0.87; 95% CI 0.64–1.18)
PMID 33670108 · one of two readings recorded this
malignant lymphoma risk
no effect
the HR of the T3 group was lower than that of the T1 group; nevertheless, the difference was not significant (HR, 0.72; 95%CI, 0.48–1.10)
PMID 33670108 · one of two readings recorded this
mean dietary acrylamide intake estimated from dietary records
while the mean intake estimated from DRs were 6.78 μg per day (SD = 3.89) and 7.25 μg per day (SD = 3.33), respectively
PMID 33670108 · one of two readings recorded this
mean dietary acrylamide intake estimated from dietary records
while the mean intake estimated from DRs were 6.78 μg per day (SD = 3.89) and 7.25 μg per day (SD = 3.33), respectively
PMID 33670108 · one of two readings recorded this
mean dietary acrylamide intake estimated from FFQ
the mean dietary acrylamide intake estimated from the FFQ for Cohorts I and II were 7.03 μg per day (standard deviation [SD] = 4.30) and 7.14 μg per day (SD = 3.38)
PMID 33670108 · one of two readings recorded this
mean dietary acrylamide intake estimated from FFQ
the mean dietary acrylamide intake estimated from the FFQ for Cohorts I and II were 7.03 μg per day (standard deviation [SD] = 4.30) and 7.14 μg per day (SD = 3.38)
PMID 33670108 · one of two readings recorded this
median daily acrylamide intake
The median (interquartile range, IQR) daily acrylamide intake (µg/day) were 3.58 (1.45) for T1, 6.09 (1.34) for T2, and 10.11 (3.67) for T3
PMID 33670108 · one of two readings recorded this
median daily acrylamide intake
The median (interquartile range, IQR) daily acrylamide intake (µg/day) were 3.58 (1.45) for T1, 6.09 (1.34) for T2, and 10.11 (3.67) for T3
PMID 33670108 · one of two readings recorded this
median daily acrylamide intake
The median (interquartile range, IQR) daily acrylamide intake (µg/day) were 3.58 (1.45) for T1, 6.09 (1.34) for T2, and 10.11 (3.67) for T3
PMID 33670108 · one of two readings recorded this
multiple myeloma incident cases
326, 126, and 224 new cases of ML, MM, and leukemia had been identified, respectively
PMID 33670108 · one of two readings recorded this
multiple myeloma risk, interaction with smoking status
no effect, p = 0.24
The interaction term between acrylamide intake and smoking status did not show significant difference (p for interaction = 0.24)
PMID 33670108 · one of two readings recorded this
multiple myeloma risk
no effect
Although the HR of the T3 group was 0.64 (95% CI, 0.38–1.05) in multivariable-adjusted model
PMID 33670108 · one of two readings recorded this
bladder cancer incident cases
a total of 208 cases of renal cell cancer and 392 incident cases of bladder cancer were ascertained during 1,346,982 person-years of follow-up
PMID 33673718 · one of two readings recorded this
bladder cancer risk, p for trend across tertiles
no effect, p = 0.491
the HR (95% CI) in the multivariate-adjusted model was 0.89 (0.62–1.32) in the middle group (T2) and 0.87 (0.59–1.29) in the highest (T3) with respect to bladder cancer (p for trend = 0.491)
PMID 33673718 · one of two readings recorded this
bladder cancer risk
no effect
the HR (95% CI) in the multivariate-adjusted model was 0.89 (0.62–1.32) in the middle group (T2) and 0.87 (0.59–1.29) in the highest (T3) with respect to bladder cancer (p for trend = 0.491)
PMID 33673718 · one of two readings recorded this
bladder cancer risk
no effect
the HR (95% CI) in the multivariate-adjusted model was 0.89 (0.62–1.32) in the middle group (T2) and 0.87 (0.59–1.29) in the highest (T3) with respect to bladder cancer (p for trend = 0.491)
PMID 33673718 · one of two readings recorded this
incident prostate cancer and incident urinary bladder cancer (registry-ascertained, ICD-O-3) by tertile of energy-adjusted dietary acrylamide intake, multivariate Cox HR; incident renal cell cancer also measured (no outcome node)
prostate cancer HR 0.96 (0.75–1.22) for highest versus lowest tertile, multivariate-adjusted, p = 0.726
Not recorded as a finding: the direction is carried only as a signed number
Compared to the lowest intake group (T1), the HR (95% CI) in the multivariate-adjusted model was 0.92 (0.73–1.17) in the middle group (T2) and 0.96 (0.75–1.22) in the highest (T3) with respect to prostate cancer (p for trend = 0.726) (Table 3).
PMID 33673718 · one of two readings recorded this
incident prostate cancer (ICD-O-3 C61) and incident bladder cancer (C67) by cancer registry and hospital notification, multivariate Cox hazard ratio for highest vs lowest tertile of energy-adjusted dietary acrylamide intake (FFQ); renal cell cancer (C64) also measured
p = 0.726
Not recorded as a finding: the direction is carried only as a signed number
Compared to the lowest intake group (T1), the HR (95% CI) in the multivariate-adjusted model was 0.92 (0.73–1.17) in the middle group (T2) and 0.96 (0.75–1.22) in the highest (T3) with respect to prostate cancer (p for trend = 0.726) (Table 3).
PMID 33673718 · one of two readings recorded this
mean dietary acrylamide intake
The mean (± SD) dietary acrylamide intakes in the study population were 3.6 (1.5) μg/day, 6.4 (2.0) μg/day, and 11.2 (4.5) μg/day in the lowest, middle, and highest tertiles of dietary acrylamide intake, respectively
PMID 33673718 · one of two readings recorded this
mean dietary acrylamide intake
The mean (± SD) dietary acrylamide intakes in the study population were 3.6 (1.5) μg/day, 6.4 (2.0) μg/day, and 11.2 (4.5) μg/day in the lowest, middle, and highest tertiles of dietary acrylamide intake, respectively
PMID 33673718 · one of two readings recorded this
mean dietary acrylamide intake
The mean (± SD) dietary acrylamide intakes in the study population were 3.6 (1.5) μg/day, 6.4 (2.0) μg/day, and 11.2 (4.5) μg/day in the lowest, middle, and highest tertiles of dietary acrylamide intake, respectively
PMID 33673718 · one of two readings recorded this
prostate cancer incident cases
With respect to prostate cancer, 1195 cases were ascertained during 605,324 person-years of follow-up
PMID 33673718 · one of two readings recorded this
prostate cancer risk, p for trend across tertiles
no effect, p = 0.726
the HR (95% CI) in the multivariate-adjusted model was 0.92 (0.73–1.17) in the middle group (T2) and 0.96 (0.75–1.22) in the highest (T3) with respect to prostate cancer (p for trend = 0.726)
PMID 33673718 · one of two readings recorded this
prostate cancer risk
no effect
the HR (95% CI) in the multivariate-adjusted model was 0.92 (0.73–1.17) in the middle group (T2) and 0.96 (0.75–1.22) in the highest (T3) with respect to prostate cancer (p for trend = 0.726)
PMID 33673718 · one of two readings recorded this
prostate cancer risk
no effect
the HR (95% CI) in the multivariate-adjusted model was 0.92 (0.73–1.17) in the middle group (T2) and 0.96 (0.75–1.22) in the highest (T3) with respect to prostate cancer (p for trend = 0.726)
PMID 33673718 · one of two readings recorded this
renal cell cancer incident cases
a total of 208 cases of renal cell cancer and 392 incident cases of bladder cancer were ascertained during 1,346,982 person-years of follow-up
PMID 33673718 · one of two readings recorded this
renal cell cancer risk, p for trend across tertiles
no effect, p = 0.294
the HR (95% CI) in the multivariate-adjusted model was 0.83 (0.45–1.53) in the middle group (T2) and 0.71 (0.38–1.34) in the highest (T3) (p for trend = 0.294)
PMID 33673718 · one of two readings recorded this
renal cell cancer risk
no effect
the HR (95% CI) in the multivariate-adjusted model was 0.83 (0.45–1.53) in the middle group (T2) and 0.71 (0.38–1.34) in the highest (T3) (p for trend = 0.294)
PMID 33673718 · one of two readings recorded this